141 related articles for article (PubMed ID: 26402854)
21. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
Miranda ML; Macher HC; Muñoz-Hernández R; Vallejo-Vaz A; Moreno-Luna R; Villar J; Guerrero JM; Stiefel P
Am J Hypertens; 2013 Dec; 26(12):1377-80. PubMed ID: 24103646
[TBL] [Abstract][Full Text] [Related]
22. Clinical and biophysical aspects of HELLP-syndrome.
Ertan AK; Wagner S; Hendrik HJ; Tanriverdi HA; Schmidt W
J Perinat Med; 2002; 30(6):483-9. PubMed ID: 12530105
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
24. Aspartate-aminotransferase to platelet ratio index score for predicting HELLP syndrome.
Şaşmaz Mİ; Ayvaz MA; Dülger AC; Kuday Kaykısız EK; Güven R
Am J Emerg Med; 2020 Mar; 38(3):459-462. PubMed ID: 30777375
[TBL] [Abstract][Full Text] [Related]
25. Soluble endoglin in preeclamptic patients with or without HELLP syndrome.
Hertig A; Fort J; Lefevre G; Chabbert-Buffet N; Uzan M; Rondeau E; Rozenberg P
Am J Obstet Gynecol; 2010 Jun; 202(6):594.e1-4. PubMed ID: 20430360
[TBL] [Abstract][Full Text] [Related]
26. Nuclear transcription factor-kappa beta-dependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case-control study.
Simsek Y; Gul M; Celik O; Aydin NE; Arda Düz S; Celik E; Ozerol E; Özerol IH; Tanbek K
Hypertens Pregnancy; 2013 Aug; 32(3):281-91. PubMed ID: 23905607
[TBL] [Abstract][Full Text] [Related]
27. Anxiety and depression following preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. A systematic review.
Delahaije DH; Dirksen CD; Peeters LL; Smits LJ
Acta Obstet Gynecol Scand; 2013 Jul; 92(7):746-61. PubMed ID: 23679343
[TBL] [Abstract][Full Text] [Related]
28. First-trimester placental growth factor as a marker for hypertensive disorders and SGA.
Cowans NJ; Stamatopoulou A; Matwejew E; von Kaisenberg CS; Spencer K
Prenat Diagn; 2010 Jun; 30(6):565-70. PubMed ID: 20509158
[TBL] [Abstract][Full Text] [Related]
29. Can SIRI or other inflammatory indices predict HELLP syndrome in the first trimester?
İpek G; Tanaçan A; Ağaoğlu Z; Peker A; Şahin D
J Reprod Immunol; 2023 Sep; 159():104126. PubMed ID: 37573651
[TBL] [Abstract][Full Text] [Related]
30. The HELLP syndrome.
Kirkpatrick CA
Acta Clin Belg; 2010; 65(2):91-7. PubMed ID: 20491358
[TBL] [Abstract][Full Text] [Related]
31. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
[TBL] [Abstract][Full Text] [Related]
32. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.
Browning MF; Levy HL; Wilkins-Haug LE; Larson C; Shih VE
Obstet Gynecol; 2006 Jan; 107(1):115-20. PubMed ID: 16394048
[TBL] [Abstract][Full Text] [Related]
33. Recurrence risks of hypertensive diseases in pregnancy after HELLP syndrome.
Leeners B; Neumaier-Wagner PM; Kuse S; Mütze S; Rudnik-Schöneborn S; Zerres K; Rath W
J Perinat Med; 2011 Nov; 39(6):673-8. PubMed ID: 21809897
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study).
Delahaije DH; van Kuijk SM; Dirksen CD; Sep SJ; Peeters LL; Spaanderman ME; Bruinse HW; de Wit-Zuurendonk LD; van der Post JA; Duvekot JJ; van Eyck J; van Pampus MG; van der Hoeven MA; Smits LJ
BMC Pregnancy Childbirth; 2010 Oct; 10():60. PubMed ID: 20932350
[TBL] [Abstract][Full Text] [Related]
35. Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound.
Kawabata I; Nakai A; Takeshita T
Arch Gynecol Obstet; 2006 Aug; 274(5):303-9. PubMed ID: 16680464
[TBL] [Abstract][Full Text] [Related]
36. OS087. Maternal characteristics, mean arterial pressure and PLGF in early prediction of preeclampsia.
Kuc S; Koster MP; Franx A; Schielen PC; Visser GH
Pregnancy Hypertens; 2012 Jul; 2(3):225-6. PubMed ID: 26105301
[TBL] [Abstract][Full Text] [Related]
37. Hyperreactio luteinalis could be a risk factor for development of HELLP syndrome: case report.
Grgic O; Radakovic B; Barisic D
Fertil Steril; 2008 Nov; 90(5):2008.e13-6. PubMed ID: 18829007
[TBL] [Abstract][Full Text] [Related]
38. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome.
Fitzpatrick KE; Hinshaw K; Kurinczuk JJ; Knight M
Obstet Gynecol; 2014 Mar; 123(3):618-627. PubMed ID: 24499757
[TBL] [Abstract][Full Text] [Related]
39. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
[TBL] [Abstract][Full Text] [Related]
40. Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia.
Roes EM; Sieben R; Raijmakers MT; Peters WH; Steegers EA
Hypertens Pregnancy; 2005; 24(3):259-71. PubMed ID: 16263598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
